L-Moses

L-Moses A chemical probe for PCAF and GCN5 Bromodomains

This probe is available from Tocris and Cayman Chemical

overview

p300/CBP-associated factor (PCAF/KAT2B) and general control non-derepressible 5 (GCN5/KAT2A) are members of subfamily 1 of the bromodomain phylogenetic tree. These multi-domain proteins that have been implicated in retroviral infection, inflammation pathways and cancer development. However, outside of viral replication, little is known about the dependence of these effects on the C-terminal bromodomain.  L-Moses is as a chemical probe for the PCAF/GCN5 bromodomain and D-Moses is the enantiomeric negative control. Rational inhibitor design and biophysical characterization led to the discovery of L-Moses. The probe was optimized from the non-selective pan-bromodomain inhibitor, bromosporine to generate a potent, selective (>4500-fold selective over BRD4), permeable and cell-active PCAF/GCN5 bromodomain chemical probe.

Potency

PCAF Ki 47 nM in a HTRF binding competition assay using PCAF bromodomain and a biotin tagged bromodomain ligand.

PCAF KD 48 nM in a BROMOscan assay run at DiscoverX.
GCN5 KD 220 nM in a BROMOscan assay run at DiscoverX.

PCAF KD 126 nM (ITC) using PCAF bromodomain.
GCN5 KD 600 nM (ITC) using GCN5 bromodomain.

Non-family targets

GPCR/Eurofins Panel: In an panel of 130 potential off targets, L-Moses showed no binding (>60% at 10 μM) to all targets except the opioid receptors (mu 100 nM, OPRL1 840 nM, kappa 1,100 nM,) and the 5-HT transporter (220 nM).

Cellular Potency

PCAF:  IC50 220 nM in Promega NanoBRET assay, measuring displacement of NanoLuc-tagged truncated bromodomain PCAF from Halo-tagged histone H3.3 in HEK293 cells.
IC50 1.2 μM in NanoBRET assay, measuring displacement of NanoLuc-tagged full-length PCAF from Halo-tagged histone H3.3 in HEK293 cells.

IC50 660 nM for competing pull-down of full-length PCAF from cell lysates using immobilized L-Moses

GCN5: IC50 220 nM for competing pull-down of full-length PCAF from cell lysates using immobilized L-Moses.

Cytoxicity assay:

Toxicity of D-Moses and L-Moses was assessed on peripheral blood mononuclear cells  (PBMC) obtained   from   5   healthy   donors.   PBMC   were   cultured   either   with D-Moses or L-Moses at concentrations of 0.1, 1 and 10 μM or with a control (DMSO) for 24 hours. Viability of PBMC were then checked using LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (ThermoFisher Scientific). No observed cytotoxicity was observed at any concentration.

properties

Physical and chemical properties for L-Moses
Molecular weight360.2
Molecular formulaC21H24N6
MollogP2.38
PSA46.14
No. of chiral centres2
No. of rotatable bonds5
No. of hydrogen bond acceptors4
No. of hydrogen bond donors1
Physical and chemical properties for D-Moses (Negative Control)
Molecular weight360.2
Molecular formulaC21H24N6
MollogP2.38
PSA46.14
No. of chiral centres2
No. of rotatable bonds5
No. of hydrogen bond acceptors4
No. of hydrogen bond donors1
  • SMILES:
  • L-Moses: Cc1nnc2c3ccccc3c(N[C@@H](C)[C@H](c3ccccc3)N(C)C)nn12
  • D-Moses: Cc1nnc2c3ccccc3c(N[C@H](C)[C@@H](c3ccccc3)N(C)C)nn12
  • InChI:
  • D-Moses: InChI=1S/C21H24N6/c1-14(19(26(3)4)16-10-6-5-7-11-16)22-20-17-12-8-9-13-18(17)21-24-23-15(2)27(21)25-20/h5-14,19H,1-4H3,(H,22,25)/t14-,19+/m1/s1
  • InChIKey:
  • L-Moses: MSFPLTWUFWOKBX-IFXJQAMLSA-N
  • D-Moses: MSFPLTWUFWOKBX-KUHUBIRLSA-N
selectivity profile
in vitro potency
cell based assay data
references

M. Moustakim, P. G. K. Clark, L. Trulli, A. L. Fuentes de Arriba, M. T. Ehebauer, A. Chaikuad, E. J. Murphy, J. Mendez-Johnson, D. Daniels, C.-F. D. Hou, Y.-H. Lin, J. R. Walker, R. Hui, H. Yang, L. Dorrell, C. M. Rogers, O. P. Monteiro, O. Fedorov, K. V. M. Huber, S. Knapp, J. Heer, D. J. Dixon, P. E. Brennan Discovery of a PCAF Bromodomain Chemical Probe. Angew. Chem. Int. Ed. 2017, 56, 827.

pk properties
co-crystal structures
synthetic schemes

Selectivity Bromodomains

>40-fold selectivity over other bromodomain targets. (>4500-fold selective over BRD4). No observable activity on any other bromodomain target <6 µM in a BROMOscan assay run at DiscoverX.

materials and methods